Network pharmacology analysis allows comparison of two or more drugs in terms of symptoms, side effects, and gene expression to determine similarities and differences between drugs and provide new ideas for drug repositioning. In summary, we can use AI methods and technologies to test the similarity of drugs for the same disease in various ways. Our in silico drug repositioning platform represents an alternative and complementary approach for drug discovery. https://ai.computabio.com/...

Only people mentioned by VivianSmith in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Vivian Smith, click on at the bottom under it